AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Enliven Therapeutics, Inc.

$41.65 +$26.11 (+168.02%)
NASDAQ · 09 Oct 2026 13:58 UTC
Previous Close
$40.63
Day Range
$40.29$41.65
Year Range
$14.79$62.32
Market Cap
2.98B
AVG Volume
1.43M
Trailing/Forward PE
-25.56/-
PEG ratio
-4.29
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Net Income (USD) · A
-150M-100M-50M02019202020212022202320242025
ELVN Net Income (USD) by year
PeriodNet Income (USD)
2025-103.69M
2024-89.02M
2023-71.58M
2022-37.66M
2021-45.46M
2020-41.36M
2019-23.46M
Operating Income (USD) · A
-150M-100M-50M02019202020212022202320242025
ELVN Operating Income (USD) by year
PeriodOperating Income (USD)
2025-119.66M
2024-104.55M
2023-83.53M
2022-38.79M
2021-45.5M
2020-41.7M
2019-24.12M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Enliven Therapeutics, Inc.
ELVN
Stockpicker

Video analysis: ELVN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ELVN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.